Cargando…
PYY, a Therapeutic Option for Type 2 Diabetes?
Metabolic surgery leads to rapid and effective diabetes reversal in humans, by weight-independent mechanisms. The crucial improvement in pancreatic islet function observed after surgery is induced by alteration in several factors, including gut hormones. In addition to glucagon-like peptide 1 (GLP-1...
Autores principales: | Guida, Claudia, Ramracheya, Reshma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977199/ https://www.ncbi.nlm.nih.gov/pubmed/32030069 http://dx.doi.org/10.1177/1179551419892985 |
Ejemplares similares
-
Sitagliptin and Roux‐en‐Y gastric bypass modulate insulin secretion via regulation of intra‐islet PYY
por: Guida, Claudia, et al.
Publicado: (2017) -
PYY plays a key role in the resolution of diabetes following bariatric surgery in humans
por: Guida, Claudia, et al.
Publicado: (2019) -
PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery
por: Ramracheya, Reshma D., et al.
Publicado: (2016) -
Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity
por: De Silva, Akila, et al.
Publicado: (2012) -
Does PYY mediate resolution of diabetes following bariatric surgery?
por: Chelikani, Prasanth K.
Publicado: (2019)